Usage: Clobazam oral suspension is indicated as an adjunctive treatment for seizures associated with Lennox-Gastaut syndrome (LGS) in patients aged 2 years and older.
Usage: Clonazepam orally disintegrating tablets are indicated for treating seizure disorders, including Lennox-Gastaut syndrome and myoclonic seizures, as well as panic disorder with or without agoraphobia. Its long-term efficacy has not been systematically studied, prompting periodic reevaluation for ongoing use.
Usage: Clonazepam is indicated for the treatment of seizure disorders, including Lennox-Gastaut syndrome, akinetic and myoclonic seizures, and as an adjunct for absence seizures. It is also used for panic disorder, with or without agoraphobia, characterized by unexpected panic attacks. Long-term effectiveness has not been extensively studied.
Usage: Clonazepam is indicated for the treatment of seizure disorders such as Lennox-Gastaut syndrome, akinetic, and myoclonic seizures, as well as for panic disorder, with or without agoraphobia. Its efficacy for long-term use beyond nine weeks has not been systematically studied.
Usage: Clonazepam is indicated for the treatment of seizure disorders, including Lennox-Gastaut syndrome, akinetic, and myoclonic seizures, as well as absence seizures unresponsive to succinimides. It is also used to treat panic disorder, with or without agoraphobia, characterized by recurrent panic attacks.
Usage: Extended phenytoin sodium capsules are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures, as well as for the prevention and treatment of seizures occurring during or following neurosurgery.
Usage: Fosphenytoin sodium injection is indicated for controlling generalized tonic-clonic status epilepticus and preventing/treating seizures during neurosurgery. It can temporarily substitute oral phenytoin when oral administration is not feasible, but must not be given orally.
Usage: Fosphenytoin sodium injection is indicated for treating generalized tonic-clonic status epilepticus and for preventing and treating seizures during neurosurgery. It may also serve as a short-term substitute for oral phenytoin when oral administration is not feasible.
Usage: Lacosamide injection is indicated for treating partial-onset seizures and as adjunctive therapy for primary generalized tonic-clonic seizures in patients aged 4 years and older.
Usage: Lacosamide injection is indicated for treating partial-onset seizures in patients aged 4 and older and as adjunctive therapy for primary generalized tonic-clonic seizures in the same age group. Additional pediatric information is available but not included due to marketing exclusivity rights.